Corbus Pharmaceuticals (CRBP) Stock Price, Quote, News & History | Benzinga

Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price, Quote, News & History

CRBPNASDAQ

Trade with Public

Trade with Public

$11.46

-0.02-0.17%

At close: Sep 2, 5:00 PM EST

$11.55

0.070.61%

Pre-Market: 4:02 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$11.46

Volume / Avg.

0 / 438.63K

Day Range

- - -

52 Wk Range

7.12 - 20.56

Market Cap

$223.39M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

12.71%

Days to Cover

6.04

Recent Corbus Pharmaceuticals Holdings, Inc. News

Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge

Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck cancer opportunity and obesity pipeline.

Vandana Singh

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Vandana Singh

Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now

Corbus Pharmaceuticals received buy ratings from H.C. Wainwright and Oppenheimer, citing the company's diversified pipeline.

Nicolás Jose Rodriguez

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-86.67M

Investing Cash Flow (TTM)

3.21M

Financing Cash Flow (TTM)

86.50M

Free Cash Flow (TTM)

-86.69M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.04M

Analyst Trends and Forecast

1

Mar

1

Apr

6

May

2

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$107.78M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.17

Earnings Yield % (TTM)

-53.36%

Earnings Yield % (FWD)

-40.96%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.29

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$23.37M

Debt to Equity

0.04

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$11.46

Volume / Avg.

0 / 438.63K

Day Range

- - -

52 Wk Range

7.12 - 20.56

Market Cap

$223.39M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

12.71%

Days to Cover

6.04

About

Sector

Health Care

Industry

Biotechnology

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathw...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Corbus Pharmaceuticals (CRBP) stock?

A

You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Corbus Pharmaceuticals (CRBP) competitors?

A

Other companies in Corbus Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Corbus Pharmaceuticals (CRBP) stock?

A

Corbus Pharmaceuticals has a consensus price target of $42.55.

Q

What is the current price for Corbus Pharmaceuticals (CRBP)?

A

The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $11.55 last updated September 3, 2026 at 5:41 PM EDT.

Q

Does Corbus Pharmaceuticals (CRBP) pay a dividend?

A

There are no upcoming dividends for Corbus Pharmaceuticals.

Q

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

A

Corbus Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Corbus Pharmaceuticals (CRBP) going to split?

A

There is no upcoming split for Corbus Pharmaceuticals.

Q

What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?

A

Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.